SGEN — Seagen Income Statement
0.000.00%
Last trade - 00:00
HealthcareBalancedLarge Cap
- $43.15bn
- $41.92bn
- $1.96bn
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 655 | 917 | 2,176 | 1,574 | 1,962 |
Cost of Revenue | |||||
Gross Profit | 566 | 873 | 1,958 | 1,263 | 1,552 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 915 | 1,137 | 1,579 | 2,256 | 2,575 |
Operating Profit | -260 | -221 | 597 | -682 | -613 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -246 | -159 | 616 | -676 | -602 |
Provision for Income Taxes | |||||
Net Income After Taxes | -223 | -159 | 614 | -674 | -610 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -223 | -159 | 614 | -674 | -610 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -223 | -159 | 614 | -674 | -610 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.38 | -0.959 | 3.37 | -3.7 | -3.3 |